Herpes Markers Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global herpes marker testing market, aimed at detecting the presence of herpes simplex virus (HSV) infections, has witnessed substantial growth and is projected to continue its upward trajectory during the forecast period from 2024 to 2031. This market is expected to reach even greater heights due to various factors influencing its growth.

Herpes Marker Testing Overview

Herpes marker testing serves the crucial purpose of identifying the herpes simplex virus (HSV) infection in the body, with a focus on two strains: HSV-1 and HSV-2. HSV-1 is typically associated with orofacial diseases such as cold sores, while HSV-2 primarily causes genital herpes. Diagnostic kits catering to herpes marker testing include HSV-1 kits, HSV-2 kits, and combined HSV-1/HSV-2 kits. These kits employ various laboratory diagnosis methods with varying levels of sensitivity and specificity, including viral culture, antigen & antibody-based immunoassays, and PCR amplification. The end users of these tests encompass hospitals, diagnostic centers, clinics, and academic & research institutes.

Market Drivers and Challenges

Several factors have contributed to the growth of the global herpes marker testing market. These include the prevalence of herpes infections in the population, increasing government support, growing awareness among individuals, rising healthcare expenditures, new product launches, and a growing focus on evidence-based medicine. However, challenges such as poor access to diagnostic services in remote areas, insufficient research and development initiatives, pricing pressures, and stringent regulations have acted as restraints on market revenue growth. To remain competitive in the global market, companies have been actively pursuing strategies like acquisitions, mergers, new product approvals, and launches.

Leading the Market: Antibody/Antigen-Based Kits

In terms of test types, the herpes marker testing market can be categorized into viral culture tests, nucleic acid amplification-based kits, and antibody/antigen-based kits. Among these, antibody/antigen-based kits hold the dominant position, projected to maintain a market share of approximately 50% throughout the forecast period. Physician preference and the extensive availability of these kits contribute to their prominence.

Nevertheless, nucleic acid amplification-based kits are expected to experience the highest growth rate during the forecast period, thanks to the growing acceptance of PCR technology in diagnosis due to its high sensitivity, specificity, and time efficiency.

Key Research Findings

Demand for herpes marker testing is anticipated to remain high through 2031, exhibiting a CAGR of 6.1% due to increasing demand and various supply-side growth drivers and trends.
Nucleic acid amplification-based kits, with their high sensitivity and specificity, represent the segment with the highest growth rate, followed by antibody/antigen-based kits.
Herpes marker testing products are primarily used for clinical diagnostics, reflecting significant market share and growth.
The market boasts numerous regional and international players, with strategies such as acquisitions, mergers, expansions, product launches, and the adoption of new technologies driving consumer base growth across different geographies.
North America is expected to continue being the largest consumer base in the global herpes marker testing market.

Market Segmentation

By Test Type

Viral Culture Test
Nucleic Acid Amplification-based Kits
Antibody/Antigen-based Kits

By Indication

HSV-1
HSV-2
HSV-1/HSV-2

By Application

Research-Use
Clinical Diagnostics

By End Users

Hospitals
Diagnostic Centers
Clinics
Academic & Research Institutes

By Country

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

1. Executive Summary

1.1. Global Herpes Markers Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Herpes Markers Testing Market Outlook, 2018 - 2031

3.1. Global Herpes Markers Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Viral Culture Test
  - 3.1.1.2. Nucleic Acid Amplification-based Kits
  - 3.1.1.3. Antibody/Antigen-based Kits
3.2. Global Herpes Markers Testing Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. HSV-1
  - 3.2.1.2. HSV-2
  - 3.2.1.3. HSV-1/HSV-2
3.3. Global Herpes Markers Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Research-Use
  - 3.3.1.2. Clinical Diagnostics
3.4. Global Herpes Markers Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Hospitals
  - 3.4.1.2. Diagnostic Centers
  - 3.4.1.3. Academic and Research Institutes
  - 3.4.1.4. Clinics
3.5. Global Herpes Markers Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Herpes Markers Testing Market Outlook, 2018 - 2031

4.1. North America Herpes Markers Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Viral Culture Test
  - 4.1.1.2. Nucleic Acid Amplification-based Kits
  - 4.1.1.3. Antibody/Antigen-based Kits
4.2. North America Herpes Markers Testing Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. HSV-1
  - 4.2.1.2. HSV-2
  - 4.2.1.3. HSV-1/HSV-2
4.3. North America Herpes Markers Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Research-Use
  - 4.3.1.2. Clinical Diagnostics
4.4. North America Herpes Markers Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Hospitals
  - 4.4.1.2. Diagnostic Centers
  - 4.4.1.3. Academic and Research Institutes
  - 4.4.1.4. Clinics
4.5. North America Herpes Markers Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 4.5.1.2. U.S. Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 4.5.1.3. U.S. Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.5.1.4. U.S. Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.5.1.5. Canada Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 4.5.1.6. Canada Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 4.5.1.7. Canada Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.5.1.8. Canada Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Herpes Markers Testing Market Outlook, 2018 - 2031

5.1. Europe Herpes Markers Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Viral Culture Test
  - 5.1.1.2. Nucleic Acid Amplification-based Kits
  - 5.1.1.3. Antibody/Antigen-based Kits
5.2. Europe Herpes Markers Testing Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. HSV-1
  - 5.2.1.2. HSV-2
  - 5.2.1.3. HSV-1/HSV-2
5.3. Europe Herpes Markers Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Research-Use
  - 5.3.1.2. Clinical Diagnostics
5.4. Europe Herpes Markers Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Hospitals
  - 5.4.1.2. Diagnostic Centers
  - 5.4.1.3. Academic and Research Institutes
  - 5.4.1.4. Clinics
5.5. Europe Herpes Markers Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.2. Germany Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.3. Germany Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.4. Germany Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.5. U.K. Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.6. U.K. Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.7. U.K. Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.8. U.K. Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.9. France Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.10. France Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.11. France Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.12. France Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.13. Italy Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.14. Italy Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.15. Italy Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.16. Italy Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.17. Turkey Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.18. Turkey Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.19. Turkey Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.20. Turkey Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.21. Russia Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.22. Russia Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.23. Russia Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.24. Russia Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.25. Rest of Europe Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.26. Rest of Europe Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.27. Rest of Europe Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.28. Rest of Europe Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Herpes Markers Testing Market Outlook, 2018 - 2031

6.1. Asia Pacific Herpes Markers Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Viral Culture Test
  - 6.1.1.2. Nucleic Acid Amplification-based Kits
  - 6.1.1.3. Antibody/Antigen-based Kits
6.2. Asia Pacific Herpes Markers Testing Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. HSV-1
  - 6.2.1.2. HSV-2
  - 6.2.1.3. HSV-1/HSV-2
6.3. Asia Pacific Herpes Markers Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Research-Use
  - 6.3.1.2. Clinical Diagnostics
6.4. Asia Pacific Herpes Markers Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Hospitals
  - 6.4.1.2. Diagnostic Centers
  - 6.4.1.3. Academic and Research Institutes
  - 6.4.1.4. Clinics
6.5. Asia Pacific Herpes Markers Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.2. China Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 6.5.1.3. China Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.4. China Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.5. Japan Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.6. Japan Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 6.5.1.7. Japan Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.8. Japan Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.9. South Korea Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.10. South Korea Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 6.5.1.11. South Korea Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.12. South Korea Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.13. India Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.14. India Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 6.5.1.15. India Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.16. India Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.17. Southeast Asia Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.18. Southeast Asia Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 6.5.1.19. Southeast Asia Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.20. Southeast Asia Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Herpes Markers Testing Market Outlook, 2018 - 2031

7.1. Latin America Herpes Markers Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Viral Culture Test
  - 7.1.1.2. Nucleic Acid Amplification-based Kits
  - 7.1.1.3. Antibody/Antigen-based Kits
7.2. Latin America Herpes Markers Testing Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. HSV-1
  - 7.2.1.2. HSV-2
  - 7.2.1.3. HSV-1/HSV-2
7.3. Latin America Herpes Markers Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Research-Use
  - 7.3.1.2. Clinical Diagnostics
7.4. Latin America Herpes Markers Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Hospitals
  - 7.4.1.2. Diagnostic Centers
  - 7.4.1.3. Academic and Research Institutes
  - 7.4.1.4. Clinics
7.5. Latin America Herpes Markers Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.2. Brazil Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 7.5.1.3. Brazil Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.4. Brazil Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.5.1.5. Mexico Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.6. Mexico Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 7.5.1.7. Mexico Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.8. Mexico Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.5.1.9. Argentina Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.10. Argentina Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 7.5.1.11. Argentina Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.12. Argentina Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Herpes Markers Testing Market Outlook, 2018 - 2031

8.1. Middle East & Africa Herpes Markers Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Viral Culture Test
  - 8.1.1.2. Nucleic Acid Amplification-based Kits
  - 8.1.1.3. Antibody/Antigen-based Kits
8.2. Middle East & Africa Herpes Markers Testing Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. HSV-1
  - 8.2.1.2. HSV-2
  - 8.2.1.3. HSV-1/HSV-2
8.3. Middle East & Africa Herpes Markers Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Research-Use
  - 8.3.1.2. Clinical Diagnostics
8.4. Middle East & Africa Herpes Markers Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Hospitals
  - 8.4.1.2. Diagnostic Centers
  - 8.4.1.3. Academic and Research Institutes
  - 8.4.1.4. Clinics
8.5. Middle East & Africa Herpes Markers Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.2. GCC Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 8.5.1.3. GCC Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.4. GCC Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.5. South Africa Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.6. South Africa Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 8.5.1.7. South Africa Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.8. South Africa Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.9. Egypt Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.10. Egypt Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 8.5.1.11. Egypt Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.12. Egypt Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.13. Nigeria Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.14. Nigeria Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 8.5.1.15. Nigeria Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.16. Nigeria Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Herpes Markers Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Herpes Markers Testing Market by Indication, Value (US$ Bn), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Herpes Markers Testing Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Herpes Markers Testing Market by End User, Value (US$ Bn), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Test Type vs Indication Heatmap
9.2. Manufacturer vs Indication Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Abbott Laboratories
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Test Type Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Abcam Plc
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Test Type Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. BioMerieux SA
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Test Type Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Thermo Fisher Scientific, Inc.
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Test Type Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. F. Hoffmann-La Roche Ltd.
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Test Type Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. DiaSorin S.p.A.
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Test Type Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Quidel Corporation
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Test Type Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Luminex Corporation
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Test Type Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Merck KGaA
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Test Type Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Qiagen N.V.
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Test Type Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development
- 9.5.11. Norgen Biotek Corp.
  - 9.5.11.1. Company Overview
  - 9.5.11.2. Test Type Portfolio
  - 9.5.11.3. Financial Overview
  - 9.5.11.4. Business Strategies and Development
- 9.5.12. Hologic Inc.
  - 9.5.12.1. Company Overview
  - 9.5.12.2. Test Type Portfolio
  - 9.5.12.3. Financial Overview
  - 9.5.12.4. Business Strategies and Development
- 9.5.13. Bio Rad Laboratories Inc.
  - 9.5.13.1. Company Overview
  - 9.5.13.2. Test Type Portfolio
  - 9.5.13.3. Financial Overview
  - 9.5.13.4. Business Strategies and Development
- 9.5.14. Meridian Bioscience Inc.
  - 9.5.14.1. Company Overview
  - 9.5.14.2. Test Type Portfolio
  - 9.5.14.3. Financial Overview
  - 9.5.14.4. Business Strategies and Development
- 9.5.15. Teco Diagnostics
  - 9.5.15.1. Company Overview
  - 9.5.15.2. Test Type Portfolio
  - 9.5.15.3. Financial Overview
  - 9.5.15.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations